Skip to main content

AxD clinical trials at UCSF

1 research study open to eligible people

AxD, or Alexander Disease, is a rare genetic brain disorder. UCSF is gathering clinical information and physical samples from leukodystrophy patients all over the world. This project aims to increase understanding of myelin disorders and aid scientific research.

Showing trials for
  • Myelin Disorders Biorepository Project

    open to all eligible people

    The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepository hope to use these materials to uncover new genetic etiologies for various leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these disorders. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.

    San Francisco, California and other locations

Last updated: